← All stocks

IONIS PHARMACEUTICALS INC

IONS No buying or selling
CIK 0000874015 #948 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

21 insiders · 0 transactions
11.9×

Brett P. Monia holds 11.9 times base salary in stock. $12.53M of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what Brett P. Monia last reported holding, valued at $51.60, the price Common Stock was last bought or sold at on the open market here, on 31 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Monia Brett P
Chief Executive Officer
242,760
0.1461%
$12.53M
+39.5%
BERTHELSEN SPENCER R
Director
161,233
0.0970%
$8.32M
+6.1%
Birchler Brian
EVP, Corp and Development Ops
102,883
0.0619%
$5.31M
+26.2%
HOUGEN ELIZABETH L
EVP, Finance & CFO
82,660
0.0497%
$4.27M
−11.0%
Hayden Michael R
Director
78,298
0.0471%
$4.04M
+128.8%
Schneider Eugene
EVP, Chf Clinical Develop Ofcr
77,114
0.0464%
$3.98M
+26.7%
BENNETT C FRANK
EVP, Chief Scientific Officer
60,128
0.0362%
$3.10M
−28.9%
Geary Richard S
EVP, Chief Development Officer
59,657
0.0359%
$3.08M
−29.7%
O'NEIL PATRICK R.
EVP CLO & General Counsel
59,205
0.0356%
$3.05M
+21.1%
WENDER JOSEPH H
Director
52,035
0.0313%
$2.69M
−67.6%
PARSHALL B LYNNE
Director
51,344
0.0309%
$2.65M
−41.2%
HERMAN JOAN E
Director
51,306
0.0309%
$2.65M
+22.1%
Baroldi Joseph
EVP, Chief Business Officer
49,578
0.0298%
$2.56M
+129.6%
LOSCALZO JOSEPH
Director
36,330
0.0219%
$1.87M
−20.6%
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
23,713
0.0143%
$1.22M
+1,092%
Kordasiewicz Holly B.
EVP, Chief Development Officer
22,096
0.0133%
$1.14M
+42.7%
Swayze Eric
EVP Research
22,077
0.0133%
$1.14M
−36.9%
Devers Shannon L.
EVP, Chief Human Resources Ofc
16,348
0.0098%
$843.56K
+106.7%
KLEIN JOSEPH III
Director
11,014
0.0066%
$568.32K
−32.6%
YANG MICHAEL J.
Director
7,940
0.0048%
$409.70K
Diaz Allene M.
Director
3,811
0.0023%
$196.65K
−75.8%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 329
History held since 6 Sep 2016